Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma.

Yang J, Gao T, Tang J, Cai H, Lin L, Fu S.

Mol Cell Biochem. 2013 Sep;381(1-2):9-15. doi: 10.1007/s11010-013-1677-8. Epub 2013 Jun 26.

PMID:
23801049
2.

Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.

Wang Z, Cai H, Lin L, Tang M, Cai H.

Pediatr Blood Cancer. 2014 Feb;61(2):206-10. doi: 10.1002/pbc.24763. Epub 2013 Sep 9.

PMID:
24038809
3.

Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma.

Cai H, Lin L, Cai H, Tang M, Wang Z.

Med Oncol. 2013 Jun;30(2):499. doi: 10.1007/s12032-013-0499-6. Epub 2013 Feb 22.

PMID:
23430441
4.

Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.

Zhang H, Yin Z, Ning K, Wang L, Guo R, Ji Z.

Hum Pathol. 2014 Jul;45(7):1430-6. doi: 10.1016/j.humpath.2014.02.018. Epub 2014 Mar 5.

PMID:
24784921
5.

Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.

Li X, Yang H, Tian Q, Liu Y, Weng Y.

Neoplasma. 2014;61(4):453-60. doi: 10.4149/neo_2014_056.

PMID:
24645838
6.

Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.

Zou P, Ding J, Fu S.

Pathol Res Pract. 2017 Mar;213(3):194-198. doi: 10.1016/j.prp.2016.12.020. Epub 2016 Dec 29.

PMID:
28214202
7.

Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.

Mu Y, Zhang H, Che L, Li K.

Med Oncol. 2014 Feb;31(2):821. doi: 10.1007/s12032-013-0821-3. Epub 2013 Dec 19.

PMID:
24352761
8.

The expression and function of miRNA-451 in osteosarcoma.

Yuan J, Lang J, Liu C, Zhou K, Chen L, Liu Y.

Med Oncol. 2015 Jan;32(1):324. doi: 10.1007/s12032-014-0324-x. Epub 2014 Dec 4.

PMID:
25471786
9.

Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.

Li RZ, Wang LM.

World J Surg Oncol. 2016 May 18;14:150. doi: 10.1186/s12957-016-0900-y.

10.

Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma.

Tang J, Zhao H, Cai H, Wu H.

Biomed Pharmacother. 2015 Apr;71:222-6. doi: 10.1016/j.biopha.2015.01.025. Epub 2015 Feb 7.

PMID:
25960240
11.

Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.

Zeng H, Zhang Z, Dai X, Chen Y, Ye J, Jin Z.

Pathol Oncol Res. 2016 Apr;22(2):253-60. doi: 10.1007/s12253-015-9901-3. Epub 2015 Jun 18.

PMID:
26183062
12.

Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma.

Cai H, Lin L, Cai H, Tang M, Wang Z.

Int J Mol Sci. 2014 Jan 6;15(1):560-73. doi: 10.3390/ijms15010560.

13.

Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.

Yang Z, Zhang Y, Zhang X, Zhang M, Liu H, Zhang S, Qi B, Sun X.

Biomed Pharmacother. 2015 Oct;75:153-8. doi: 10.1016/j.biopha.2015.07.018. Epub 2015 Sep 28.

PMID:
26422796
14.

Prognostic value of the microRNA-29 family in patients with primary osteosarcomas.

Hong Q, Fang J, Pang Y, Zheng J.

Med Oncol. 2014 Aug;31(8):37. doi: 10.1007/s12032-014-0037-1. Epub 2014 Jul 12.

PMID:
25015394
15.

Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.

Liu W, Zhao ZY, Shi L, Yuan WD.

Diagn Pathol. 2015 Jul 21;10:116. doi: 10.1186/s13000-015-0329-6.

16.

Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.

Wang S, Li Q, Wang K, Dai Y, Yang J, Xue S, Han F, Zhang Q, Liu J, Wu W.

Clin Transl Oncol. 2013 Oct;15(10):849-54. doi: 10.1007/s12094-013-1014-4. Epub 2013 Feb 14.

PMID:
23408039
17.

miR-21 predicts poor prognosis in patients with osteosarcoma.

Ren X, Shen Y, Zheng S, Liu J, Jiang X.

Br J Biomed Sci. 2016 Oct;73(4):158-162.

PMID:
27922432
18.

MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma.

Tang M, Lin L, Cai H, Tang J, Zhou Z.

Onco Targets Ther. 2013 Jul 8;6:833-8. doi: 10.2147/OTT.S40080. Print 2013.

19.

Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.

Taheriazam A, Bahador R, Karbasy SH, Jamshidi SM, Torkaman A, Yahaghi E, Shakeri M.

Diagn Pathol. 2015 Sep 17;10:166. doi: 10.1186/s13000-015-0400-3. Retraction in: Diagn Pathol. 2016 Nov 2;11(1):111.

20.

MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.

Xu SH, Yang YL, Han SM, Wu ZH.

World J Surg Oncol. 2014 Jun 27;12:195. doi: 10.1186/1477-7819-12-195.

Supplemental Content

Support Center